WebApr 4, 2024 · Filing date Form Description View; Apr 04, 2024: 4: Statement of changes in beneficial ownership of securities. View HTML WebHere, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Incyte's ongoing operational relationships across important fundamental and technical indicators. Latest Incyte Corporation Q4 2024 Earnings Call Transcript INCY 81.24 0.74 Low 80.29 High 81.49 Alpha 0.0623 Beta 0.1
INCY 13F Hedge Fund and Asset Management Owners
WebScherle was one of the original team of scientists that joined Incyte in 2002 and was involved in the discovery and development of the JAK inhibitors, Jakafi® (ruxolitinib), for the treatment of myelofibrosis and polycythemia vera, and Olumiant® (baricitinib), for rheumatoid arthritis, as well as the advancement of >10 small molecules into … WebApr 9, 2024 · The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Incyte news, EVP … in china\u0027s case
Sumitomo Mitsui Trust Holdings Inc. Sells 32,657 Shares of Incyte …
WebOct 25, 2024 · Incyte gains exclusive, worldwide development and commercialization rights to MGA012 in all indications; ... the availability or commercial potential of MacroGenics' product candidates and other risks described in MacroGenics' filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press ... WebApr 11, 2024 · SVB Securities raised Incyte from an “underperform” rating to a “market perform” rating and set a $61.00 target price on the stock in a research note on Friday, … WebApr 6, 2024 · Incyte Corp. – Filings and Transcripts – BamSEC Incyte Corp. Watch NASDAQ: INCY Share price (3/29/23): $71.14 Market cap (3/29/23): $15.9 billion 8 Incyte Corp. … incarcerated sliding inguinal hernia cpt